Based on the TCGA dataset and CGGA dataset, our results showed that CD96 expression was much higher in mesenchymal-molecular subtype glioma, compared to that in the other three subtypes (Fig. 2A,B). The gene discussed is CD96; the disease is central nervous system cancer.